Compare PAGP & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAGP | TFX |
|---|---|---|
| Founded | 2013 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 2013 | 1994 |
| Metric | PAGP | TFX |
|---|---|---|
| Price | $23.87 | $121.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $22.11 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.7M | 871.7K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.90% | 1.02% |
| EPS Growth | ★ 370.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $44,262,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $10.57 | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $90.46 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.69 | $100.18 |
| 52 Week High | $24.76 | $139.67 |
| Indicator | PAGP | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 45.77 |
| Support Level | $22.69 | $117.09 |
| Resistance Level | $24.00 | $126.13 |
| Average True Range (ATR) | 0.34 | 4.81 |
| MACD | 0.09 | -1.17 |
| Stochastic Oscillator | 69.67 | 6.28 |
Plains GP Holdings LP owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), and natural gas. The group manages its operations through two operating segments: Crude Oil segment operations generally consist of gathering and transporting crude oil using pipelines (including gathering systems), trucks, and, at times, on barges or railcars; and NGL segment operations involve NGL storage and terminalling from NGL assets located in the Southwestern United States. It generates the majority of its revenue from the Crude Oil segment. Its geographic markets are the United States and Canada. It generates the majority of its revenue from the United States.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.